[Direct answer]In the Beijing area, subjects have the right to withdraw from clinical trials at any time without any conditions. According to regulations and laws, there will generally be no "trouble", and they should not be discriminated against or retaliated against for doing so. According to the "Quality Management Standards for Clinical Trials of Drugs" (implemented on July 1, 2020), subjects can withdraw without giving a reason; according to Article 1008 of the "Civil Code of the People's Republic of China", clinical trials must undergo ethical review and obtain the subject's written informed consent. After withdrawal, the reasonable examination and treatment costs that have occurred will generally be handled in accordance with the trial protocol and the informed consent form, and the reasonable costs already incurred will not be automatically waived. It is recommended to keep the informed consent form, communication records, and expense vouchers before withdrawal to facilitate clarifying rights and interests. For more details, please refer to the following link:Legal services for personal injury and medical disputes.

I. Problem Background and Typical Scenarios

It's not uncommon for subjects to withdraw from clinical trials. Common situations include: discomfort or side effects after taking medication, doubts about the effectiveness of the treatment, conflicts with personal schedules, or simply not wanting to continue. Many subjects worry that "once they sign the informed consent, they can't change their mind", "they'll have to pay compensation if they withdraw", or "they'll be affected when seeking medical treatment at this hospital in the future". Most of these concerns stem from misunderstandings of the rules. The core of the informed consent form is "informed voluntary participation", not a contract of servitude; subjects, as natural persons, enjoy the freedom to withdraw. In cases involving medical harm and disputes over informed consent, relevant provisions can be referred to for resolution.Legal services for personal injury and medical disputesEvaluate the equity.

II. Key points of contention

The focus of the controversy lies in three aspects. Firstly, whether withdrawal constitutes a breach of contract: standard clinical trials are based on the principle of voluntariness, and the withdrawal of subjects does not constitute a breach of contract. Sponsors are not allowed to exert pressure or hold them accountable. Secondly, fees and compensation: how to handle the reasonable inspection and treatment costs that have occurred, whether to stop providing compensation after withdrawal, and whether to return the compensation that has been received, depending on the provisions of the protocol and the informed consent form. Thirdly, health continuity: how to continue the treatment of the original condition after withdrawal, and how to use the research data. For cases involving work-related injuries or damage caused by trials in labor scenarios, reference can be made to relevant regulations.Labor arbitration and legal services for work-related injury compensationDetermine the relief path.

III. Professional analysis by Hengluo Law Firm

Based on practical observations in the field of medical disputes, the most common reason for subjects withdrawing from disputes is unclear agreements on "fees and compensation". According to Article 1008 of the Civil Code, clinical trials must inform subjects of the trial's purpose, use, and potential risks in detail and obtain their written consent; Article 1009 requires that relevant medical research activities comply with ethics and do not harm human health. A standard informed consent form will specify the right to withdraw and the method of fee settlement. After withdrawing, subjects only need to settle reasonable fees according to the agreement and will not incur additional legal liabilities. Hengluo Lawyers usually advise: Before signing, read the informed consent form on withdrawal and fee provisions in full; when withdrawing, notify in writing and keep the receipt; if subjected to coercion, concealment of risks, or unreasonable accountability after withdrawal, they can claim that their rights have been infringed and seek legal intervention. For compensation requests, they can proceed accordingly.Legal services for creditor-debtor disputes and enforcement cases.

IV. Practical suggestions and legal basis

The legal basis is Article 1008 of the Civil Code of the People's Republic of China (effective January 1, 2021), which stipulates that clinical trials must undergo ethical review, involve informed risk disclosure, and require written consent; Article 1009 (medical research must comply with ethical standards, not harm health, and not violate public interests); and the supporting Guidelines for Quality Management of Drug Clinical Trials (effective July 1, 2020), which regulate subjects' voluntary participation and withdrawal from trials, non-discrimination or retaliation against withdrawal, data confidentiality, and expense settlement. Practical advice: Before participating, carefully read the informed consent form, focusing on withdrawal rights, expense and compensation, data use, and adverse event reporting clauses; when withdrawing, notify the research team in writing and retain evidence of delivery; settle reasonable expenses incurred and request receipts; properly transition to regular treatment after withdrawal; if encountering coercion, insufficient risk disclosure, or improper accountability, promptly preserve evidence and consult a professional lawyer. For contractual rights determination, relevant provisions can be referenced.Legal services for corporate commercial and contract disputesReview the agreement.

5. Henglu Law Firm's Reminder

It is a statutory right for subjects to withdraw from a trial at any time without bearing any psychological burden. Remember three points: First, withdrawal is voluntary and should not lead to discrimination or retaliation. Any claim that "those who do not withdraw will be held accountable" is unfounded; Second, the fees shall be settled in accordance with the informed consent form and the trial protocol. Reasonable expenses incurred may need to be paid normally, but there will be no punitive damages; Third, withdrawal should be documented—written notifications, receipts, expense invoices, and communication records should all be preserved. If subjects suffer any harm or encounter improper treatment during the trial, they should promptly collect evidence and seek legal help. For professional support, they can seek assistance from relevant organizations or professionals.Special services and legal services for other casesEvaluate the rights protection plan.

VI. Frequently Asked Questions

Q1: If a participant withdraws from the study midway, will they be held accountable or get into trouble?

Generally, this won't happen. Participants in clinical trials are voluntary and have the right to withdraw from the trial at any time without conditions. According to the "Quality Management Standards for Clinical Trials of Drugs" and the relevant provisions of the "Civil Code", withdrawal from the trial shall not result in discrimination or retaliation, nor shall it constitute a breach of contract. The so-called "withdrawal will lead to financial compensation or legal liability" is usually not true, unless the participant seriously violates the protocol, intentionally damages the research property, etc., and the situation must be based on the agreement and evidence. The result is not "necessarily trouble", but it is protected by law. If you encounter coercion or improper accountability, you can claim that your rights have been infringed and keep evidence, and consult a lawyer if necessary.

Q2: If the subject wants to withdraw from the study, what evidence do they need to prepare and retain?

Key evidence includes: the original informed consent form (including the right to withdraw and the fee terms), application and enrollment materials, communication records with the research party (WeChat, SMS, emails, call recordings), written withdrawal notifications and delivery receipts, invoices and details of the examination and treatment costs incurred, as well as records of adverse events or side effects. The evidence should be organized around the sequence of "voluntary participation - legally entitled to the right to withdraw - settlement of reasonable costs incurred - no improper treatment upon withdrawal". The more complete the materials are, the better they can protect oneself in the settlement of fees or disputes over rights, and avoid being unilaterally deducted from compensation.

Q3: How much does it cost or involve disputes over compensation when a subject withdraws from a study? Do lawyers' fees need to be paid in such cases?

Exiting a clinical trial usually does not involve legal fees, unless there are disputes over fee settlement or damages. The reasonable costs of examination and treatment that have occurred shall be handled in accordance with the trial protocol and the informed consent form. There may be a small settlement; if there are disputes over compensation deductions, data use, or liability for damages, consulting a lawyer is usually the first step for evaluation. The formal lawyer's fees will be calculated based on the complexity and amount of the case, either on a fixed-fee or hourly basis, subject to the contract terms. There is no standard pricing. It is recommended to fix the evidence and clarify the agreements at the early stage of the dispute, as most cases can be resolved through communication to avoid the cost of litigation.

Q4: How long does it usually take from the decision to withdraw to completing the formalities?

The process is not complicated: after notifying the research team in writing, it usually takes several days to several weeks to complete the withdrawal registration, settlement of remaining fees, and data archiving. If it involves multi-center trials, fee review, or follow-up of adverse events, the period may be extended to one to several months. Overall, the withdrawal process is relatively quick; however, if there are disputes over derivative compensation or medical follow-up, the timeline will depend on the progress of negotiations or litigation. For civil litigation, the first-instance ordinary procedure takes six months and the simplified procedure takes three months. It is recommended to clarify the settlement time point and follow-up treatment arrangements at the time of withdrawal to reduce uncertainties.

Q5: I want to withdraw from the clinical trial. What are the specific steps I need to take first?

Four steps are recommended: First, re-read the "withdrawal" and "fee compensation" clauses in the informed consent form to clarify your rights and settlement rules. Second, notify the research team or principal investigator in writing (via text message, email, or letter) to express your intention to withdraw, and retain proof of delivery and confirmation from the other party. Third, cooperate with necessary withdrawal checks and adverse event follow-ups, request receipts and detailed records of expenses incurred, and settle reasonable fees according to the agreement. Fourth, properly transition to your regular medical treatment and preserve all communication and medical records. If you encounter coercion, insufficient risk disclosure, or improper accountability, immediately preserve evidence and consult a professional lawyer to protect the rights of the subject in accordance with the law.

This article is written based on the common judicial interpretations in the Beijing area. If the case occurs in other regions, it is recommended to consult local lawyers to verify the regional differences.

If you are currently facing similar problems, it is recommended that you consult a professional lawyer as soon as possible with the relevant evidence materials, to avoid missing the statutory time limits. →Personal injury legal services·Beijing Henglu Law Firm

Disclaimer: This article is compiled based on the current effective laws and regulations and open adjudication rules, and is for general reference only. It does not constitute a formal legal opinion on specific cases. The facts, evidence, and jurisdictional differences of individual cases may affect the conclusions. In case of disputes, please consult a practicing lawyer in time.